Lv11
40 积分 2024-03-27 加入
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma
12天前
已完结
Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis
12天前
已完结
Novel CRBN-Recruiting Proteolysis-Targeting Chimeras as Degraders of Stimulator of Interferon Genes with In Vivo Anti-Inflammatory Efficacy
1个月前
已完结
A Novel Lysosome Targeting Chimera for Targeted Protein Degradation via Split-and-Mix Strategy
5个月前
已完结
Selective Protein of Interest Degradation through the Split-and-Mix Liposome Proteolysis Targeting Chimera Approach
5个月前
已完结
Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines
5个月前
已完结
Structural analysis of human KDM5B guides histone demethylase inhibitor development
8个月前
已完结
KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma
8个月前
已完结
KDM5B predicts temozolomide-resistant subclones in glioblastoma
8个月前
已完结
Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
8个月前
已完结
皖公网安备34019202002308
